Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 4.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 11.85
  • 52 Week Low: 3.40
  • Currency: UK Pounds
  • Shares Issued: 533.35m
  • Volume: 255,065
  • Market Cap: £22.67m

Eden Research signs two Sumitimo crop trial deals

Date: Wednesday 20 May 2015

LONDON (ShareCast) - Two products developed by Oxford-based crop improvement specialist Eden Research have been signed up for trials that could lead to licence deals with an existing client owned by Japanese conglomerate Sumitomo.
Sumitomo's Spanish and Italian chemicals businesses, Sipcam Italia and Sipcam Iberia, have signed evaluation agreements to carry out field trials on two new Eden products targeting important crop diseases.

Following successful work with 3AEY, Eden's treatment for botrytis, that saw Sipcam taking an exclusive licence in November, two trials throughout the rest of 2015 will now focus on the treatment of powdery mildew, which affects flowers and fruit, and apple scab with evaluation.

Should these trials prove successful, licence agreements could be signed in 2016 although Eden did not disclose details regarding potential financial value of such deals.

Powdery mildew and apple scab are both major diseases affecting high value crops.

Eden chief executive Sean Smith said: "We are pleased with the increase in activities with our partner, Sipcam. This is clear evidence that we are realising the potential to expand the commercialisation of our products and grow the existing relationship with Sumitomo related companies around the world."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Eden Research Market Data

Currency UK Pounds
Share Price 4.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 11.85
52 Week Low 3.40
Volume 255,065
Shares Issued 533.35m
Market Cap £22.67m

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
33.98% below the market average33.98% below the market average33.98% below the market average33.98% below the market average33.98% below the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Income Not Available
Growth
5.67% above the market average5.67% above the market average5.67% above the market average5.67% above the market average5.67% above the market average
5.56% above the sector average5.56% above the sector average5.56% above the sector average5.56% above the sector average5.56% above the sector average

Eden Research Dividends

No dividends found

Trades for 26-Apr-2024

Time Volume / Share Price
15:25 10,000 @ 4.33p
13:14 8,000 @ 4.33p
12:31 15,000 @ 4.34p
12:18 7,533 @ 4.34p
12:18 7,936 @ 4.17p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page